Karl Deisseroth Takes Home Science’s Most Valuable Award

The Stanford University psychiatrist and neuroscientist known for his contributions to optogenetics and tissue clearing is awarded €4 million by the Fresenius Research Prize.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

STEVE FISCH/STANFORD SCHOOL OF MEDICINEThe 2017 Fresenius Research Prize—the most valuable award for scientific achievement—goes to Karl Deisseroth, a Stanford University professor and Howard Hughes Medical Institute investigator who helped develop the pioneering techniques of optogenetics and CLARITY tissue clearing. Deisseroth is also known for his research on the underlying neural circuitry of depression.

The award honors an individual scientist every four years by the Else Kroner-Fresenius Foundation in Germany. It comes with a cash value of €4 million ($4.47 million), and 2017 is the second time it’s been handed out. Of the total, €3.5 million will be earmarked for Deisseroth’s lab, while the remaining €500,000 are for his personal use.

While Deisseroth is in Berlin to accept the award and present a talk on his research, he emailed with The Scientist about his career and this latest achievement.

The Scientist: You’re known for so many scientific advances—optogenetics, CLARITY, neural mechanisms of depression—what do you consider your proudest achievement?

Karl Deisseroth: Well, as a psychiatrist it’s humbling to realize how far we have to go still. It’s one thing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies